Company: INGN
Filing Date: 2025-03-27
Form Type: DEF 14A
Source: 0000950170-25-045737
Chunk: 24

Company: Inogen Inc
Filing Date: 2025-03-27
Form: DEF 14A
Chunk 24
---
.inogen.com/corporate-governance/governance-documents. During 2024, our Compensation Committee held six meetings.

The Compensation Committee regularly reviews the services provided by its outside consultants and believes that Mercer LLC (“Mercer”), a subsidiary of Marsh & McLennan Companies, Inc., and Pearl Meyer & Partners, LLC (“Pearl Meyer”) are independent in providing executive compensation consulting services. Mercer is the Company’s current executive compensation consultant. Pearl Meyer performed the Company’s executive compensation consulting services from 2013 through June 2024. The transition of compensation consulting services was not the result of any disagreement with us relating to our policies or practices related to executive compensation. The Compensation Committee continues to monitor the independence of its compensation consultant on a periodic basis.

Compliance Committee

The current members of our Compliance Committee are Mr. King (Chairperson), Ms. Sahney and Mr. Boehnlein. Ms. Sahney was appointed to the Compliance Committee in connection with her appointment to the Board in January 2025. Mr. King was appointed to the Compliance Committee in March 2024. Mr. West served on the Compliance Committee until his resignation from the Board in January 2025. Our Compliance Committee oversees our compliance with healthcare, legal and regulatory requirements. Our Compliance Committee also:

<div align='center'>-14-</div>

oversees compliance programs in the healthcare, legal and regulatory areas, and other legal and regulatory requirements not overseen by the Audit Committee;

provides an avenue of communication among management, those persons responsible for internal compliance functions in these areas, and the Board; and

oversees corporate responsibility matters of the Company not overseen by the Audit Committee.

Our Compliance Committee operates under a written charter that satisfies the listing standards of the Nasdaq Global Select Market. During 2024, our Compliance Committee held four meetings.

Nominating and Governance Committee

The current members of our Nominating and Governance Committee are Ms. Rider (Chairperson), Ms. Sahney and Ms. Mora. Ms. Sahney was appointed to the Nominating and Governance Committee in January 2025. Mr. West was appointed to the Nominating and Governance Committee in April 2023 and served on the committee until his resignation from the Board in January 2025. The composition of our Nominating and Governance Committee meets the requirements for independence under current Nasdaq Global Select Market listing standards and SEC rules and regulations. Our Nominating and Governance Committee oversees our plans and benefits programs. Our